CVS rallies on turnaround momentum and EPS growth, while CI is a defensive play with stable returns and a focused healthcare ...

New research from Cigna Healthcare delves into the importance of health insurance literacy, which is the ability to ...

Cigna will cap out-of-pocket costs at $200 per month for patients using the weight-loss drugs Wegovy and Zepbound through an ...

Cigna subsidiary Evernorth Health Services will automate prior authorizations for GLP-1 weight-loss drugs under a new program ...

Cigna Group’s drug benefit unit is offering a new way for health plans to cover expensive weight-loss drugs that it says will ...

Getting access to popular weight loss drugs will be simpler and cheaper for some.Health insurer Cigna (CI) announced a new ...

UBS analyst AJ Rice reaffirmed a “Buy” rating on The Cigna Group (NYSE:CI) with a price target of $390. Rice shared his views ...

Health insurance company Cigna (NYSE:CI) in Q1 CY2025, with sales up 14.4% year on year to $65.5 billion. Its non-GAAP profit ...

This was the stock's second consecutive day of losses.

The health insurer is accused of using forfeited funds from departing employees to reduce employer contributions to the ...

Cigna Corporation (NYSE:CI), a leading global health service organization, has been navigating a complex healthcare landscape with a mix of strategic initiatives and market challenges. Recent ...

U.S. prices for new drugs more than doubled last year compared to 2021, as companies developed more therapies for rare ...